
Sign up to save your podcasts
Or
Therapeutic options for frontline management of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) are rapidly evolving. Are you up to date on the evidence? Credit available for this activity expires: 09/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001657?ecd=bdc_podcast_libsyn_mscpedu
4
77 ratings
Therapeutic options for frontline management of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) are rapidly evolving. Are you up to date on the evidence? Credit available for this activity expires: 09/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001657?ecd=bdc_podcast_libsyn_mscpedu
135 Listeners
13 Listeners
315 Listeners
107 Listeners
866 Listeners
251 Listeners
495 Listeners
686 Listeners
18 Listeners
279 Listeners
3,321 Listeners
1,108 Listeners
195 Listeners
517 Listeners
349 Listeners
60 Listeners
25 Listeners
427 Listeners
366 Listeners